Devices/Recall·openFDA/device

Orthofix U.S. LLC — Class II: Orthofix MINIRAIL, STANDARD LENGTHENER Model/Catalog Number: M101, Unilateral orthopedic/

MediumPublished Jul 22, 2026· AI-analyzed Jul 27, 2026View original FDA source
AI-generated regulatory interpretation. The four sections below are an analyst-style summary produced by an AI model from the original FDA source. Always verify against the source before any regulatory, clinical, or commercial decision.
What happened

Orthofix U.S. LLC has initiated a Class II recall for certain Minirail unilateral external fixation devices due to mislabeling. Model M101 was incorrectly labeled as M103, M103 was labeled as M101, and M122 was labeled as M111.

Who it affects

Orthofix U.S. LLC, orthopedic surgical facilities, sterile processing departments, and regulatory/quality teams managing unilateral external fixation devices.

Why it matters

The transposition of model numbers introduces significant risks for procedural errors, potentially leading to the selection of an incorrect device length or specification during surgery. This suggests a failure in the labeling verification or packaging process, necessitating an investigation into the point of origin for these labeling discrepancies.

Practical takeaway

Immediately verify existing inventory for the specified model numbers against labeling specifications. Conduct a reconciliation of labeling processes to identify where transposition occurred, and review current labeling verification procedures for external fixation components.

FDA source material

Class II. Reason: Unilateral external fixation devices may be incorrectly labeled. Minirail M101 was labeled as M103, Minirail M103 was labeled as M101, and Minirail M122 was labeled as M111. Product: Orthofix MINIRAIL, STANDARD LENGTHENER Model/Catalog Number: M101, Unilateral orthopedic/trauma external fixation device. Firm: Orthofix U.S. LLC (Lewisville TX United States). Status: Ongoing.

Open in openFDA / FDA.gov
AI-generated interpretation. Always verify critical decisions against the original FDA source. Generated with google/gemini-3-flash-preview.